Life-sciences-focused venture capital firm Forbion has held a first close on €185m for its Growth Opportunities Fund, which will focus on investments at a later stage than the firm’s previous vehicles in European biotech companies.
Life-sciences-focused venture capital firm Forbion has held a first close on €185m for its Growth Opportunities Fund, which will focus on investments at a later stage than the firm’s previous vehicles in European biotech companies.